Certified by Founder Lodge
GC Cell
Korea, Republic Of - Yongin-si, Gyeonggi-do
INVESTOR
1 Disclosed Funding Rounds $16,500,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
GC Cell has various pipelines based on NK, T, and stem cells. GC Cell has excellent research capabilities and global-level cell therapy products based on solid platform technology from initia
| Company | Date | Round | Raised |
|---|---|---|---|
 Feldan Therapeutics |
June, 14 ,2023 | Series B | $16,500,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Ernesta Inc. | $20,000,000 | (Mar 12, 2026)
Standard Kernel Co. | $20,000,000 | (Mar 12, 2026)
Option Circle | $3,000,000 | (Mar 12, 2026)
Translucent AI | $27,000,000 | (Mar 12, 2026)
zymtrace | $12,200,000 | (Mar 12, 2026)
